z-logo
Premium
The topoisomerase I poison camptothecin generates a Chk1‐dependent DNA damage checkpoint signal in fission yeast
Author(s) -
Wan Shanhong,
Capasso Holly,
Walworth Nancy C.
Publication year - 1999
Publication title -
yeast
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.923
H-Index - 102
eISSN - 1097-0061
pISSN - 0749-503X
DOI - 10.1002/(sici)1097-0061(199907)15:10a<821::aid-yea422>3.0.co;2-#
Subject(s) - g2 m dna damage checkpoint , dna damage , chek1 , biology , topoisomerase , camptothecin , schizosaccharomyces pombe , cell cycle checkpoint , microbiology and biotechnology , dna repair , dna replication , dna , cell cycle , biochemistry , saccharomyces cerevisiae , apoptosis , yeast
The protein kinase Chk1 is essential for the DNA damage checkpoint. Cells lacking Chk1 are hypersensitive to DNA‐damaging agents such as UV light and γ‐irradiation because they fail to arrest the cell cycle when DNA damage is generated. Phosphorylation of Chk1 occurs after DNA damage and is dependent on the integrity of the DNA damage checkpoint pathway. We have tested whether a topoisomerase I inhibitor, camptothecin (CPT), generates DNA damage in the fission yeast Schizosaccharomyces pombe that results in Chk1 phosphorylation. We demonstrate that Chk1 is phosphorylated in response to CPT treatment in a time‐ and dose‐dependent manner and that phosphorylation is dependent on an intact DNA damage checkpoint pathway. Furthermore, we show that cells must be actively dividing in order for CPT to generate a Chk1‐responsive DNA damage signal. This observation is consistent with a model whereby the cytotoxic event caused by CPT treatment is the production of a DNA double‐strand break resulting from the collision of a DNA replication fork with a trapped CPT‐topoisomerase I cleavable complex. Cells lacking Chk1 are hypersensitive to CPT treatment, suggesting that the DNA damage checkpoint pathway can be an important determinant for CPT sensitivity or resistance. Finally, as a well‐characterized, soluble agent that specifically causes DNA damage, CPT will allow a biochemical analysis of the checkpoint pathway that responds to DNA damage. Copyright © 1999 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here